Viromed Medical AG | WebDisclosure

BRIEF

published on 11/26/2024 at 08:05, 1 year 7 months ago

Viromed Medical AG fait progresser la recherche sur le plasma froid pour la santé pulmonaire

Résistance Aux Antibiotiques Viromed Medical AG Plasma Froid Innovation Dans Le Domaine De La Santé Pneumonie Associée À La Ventilation Mécanique
PRESS RELEASE

published on 11/26/2024 at 08:00, 1 year 7 months ago

Viromed Medical AG: cold plasma as a digital antibiotic for the lungs
Viromed Medical AG is advancing research into cold plasma as a 'digital antibiotic' for improving treatment of ventilator-associated pneumonia, with potential to revolutionize healthcare

Viromed Medical AG Cold Plasma Ventilator-associated Pneumonia Healthcare Revolution Digital Antibiotic
BRIEF

published on 09/17/2024 at 15:45, 1 year 9 months ago

Viromed Medical AG Announces Plans to Acquire ActivCell Group AG

Mergers & Acquisitions Medical Device Regulation Viromed Medical AG Cold Plasma Therapy ActivCell Group AG
BRIEF

published on 09/17/2024 at 15:45, 1 year 9 months ago

Viromed Medical AG annonce son intention d'acquérir ActivCell Group AG

Fusions Et Acquisitions Viromed Medical AG Groupe ActivCell SA Thérapie Par Plasma Froid Réglementation Sur Les Dispositifs Médicaux
PRESS RELEASE

published on 09/17/2024 at 15:40, 1 year 9 months ago

EQS-Adhoc: Viromed Medical AG plans to acquire all shares of ActivCell Group AG by way of a capital increase against contribution in kind with exclusion of subscription rights
Viromed Medical AG plans to acquire all shares of ActivCell Group AG by capital increase excluding subscription rights, strategically expanding product portfolio

Acquisition Capital Increase Product Portfolio Viromed Medical AG ActivCell Group AG
BRIEF

published on 09/02/2024 at 10:05, 1 year 9 months ago

Viromed Medical AG: Successful Start of Trading on XETRA

XETRA Trading Growth Potential Investor Base Viromed Medical AG Cold Plasma Technology
BRIEF

published on 09/02/2024 at 10:05, 1 year 9 months ago

Viromed Medical AG : Début de cotation réussi sur XETRA

Potentiel De Croissance Viromed Medical AG Négociation XETRA Base D'investisseurs Technologie Plasma Froid
PRESS RELEASE

published on 09/02/2024 at 10:00, 1 year 9 months ago

Viromed Medical AG: Successful start of trading on XETRA
Viromed Medical AG successfully starts trading on XETRA, aiming to expand cold plasma technology use in medical field, increase liquidity, and attract more investors

Liquidity XETRA Trading Investor Base Viromed Medical AG Cold Plasma Technology
BRIEF

published on 07/10/2024 at 07:35, 1 year 11 months ago

Viromed Medical AG Seeks Special Approval for Cold Plasma Device for VAP Prevention

Medical Technology Antimicrobial Viromed Medical AG Cold Plasma Ventilator-associated Pneumonia
BRIEF

published on 07/10/2024 at 07:35, 1 year 11 months ago

Viromed Medical AG demande une approbation spéciale pour un dispositif à plasma froid destiné à la prévention des PAV

Technologie Médicale Viromed Medical SA Plasma Froid Pneumonie Associée Au Ventilateur Antimicrobien

Published on 06/27/2026 at 01:40, 8 hours 18 minutes ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 9 hours 58 minutes ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 10 hours 58 minutes ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 11 hours 8 minutes ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 11 hours 43 minutes ago

Revive Therapeutics Announces Proposed Private Placement

View all ACCESSWIRE

Published on 06/27/2026 at 00:05, 9 hours 53 minutes ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 9 hours 54 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 10 hours 22 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 10 hours 22 minutes ago

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 10 hours 30 minutes ago

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE

View all EQS

Published on 06/26/2026 at 17:45, 16 hours 13 minutes ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 16 hours 13 minutes ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 16 hours 13 minutes ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 19 hours 13 minutes ago

Safran information
Published on 06/26/2026 at 14:44, 19 hours 13 minutes ago

Information Safran

View all LES ECHOS COMFI WIRE

News